Skip to content

Home - Nunavik Regional Board of Health and Social Services.
  • Inuktitut
  • English
  • Français
  • COVID-19
  • THE NRBHSS
  • Institutions
  • Documentation
  • Contact us

Search form

ePrint pageDecrease text sizeAReset text sizeAIncrease text sizeA

Professionals

  • Professionals
  • Info-MADO
  • Infectious Diseases
    • Boîte à outils - Santé respiratoire (FR)
    • COVID-19
      • COVID-19 - Psychosocial Professionals Toolkit
      • COVID-19 - Reopening Guidelines
    • Reportable Diseases (MADOs)
    • Sexually transmitted & bloodborne infection
    • Rabies and animal bites
    • Respiratory Syncytial Virus
    • Tuberculosis (TB)
  • Sexual-health
  • Ece and schools
  • Environmental Health
  • Possible Opioid Overdose
  • Training
  • Vaccination

Respiratory Syncytial Virus (RSV)

a
b
General informations

Memo - Heightened monitoring of RSV - Ungava
Memo - Heightened monitoring of RSV - Hudson
Questions - Answers on Palivizumab(French)
Checklist for the administration of Palivizumab (Synagis)
Palivizumab Administration Schedule, 2017-2018
Palivizumab Administration Schedule, 2017-2018 (French)
Evaluation of new palivizumab immunoprophylaxis recommendations in Nunavik infants, 2014-2017

a
b
Presentations

RSV Prevention in Québec 2017–2018 - Presentation by Dr. Lebel
RSV Prevention in Québec 2017–2018 - Presentation by Dr. Lebel (French) 
Palivizumab CSTU 2017-2018 (French)
Palivizumab CSI 2017-2018 (French)
Respiratory Viruses

a
b
Brochures

Informations for parents concerning Palivizymab

a
b
Usefull Links

Information sur la disponibilité du Synagis® pour la saison 2017-2018  (French)
Synagis® monograph (French)

 

Positions Available

THE NRBHSS

About us
Contact us
Careers
Complaints

 

QUICK LINKS
Professionals
Accessibility Page
Terms of Use
NRBHSS Netiquette

 FOLLOW US

 

Visit NHBRSS facebook page Visit NHBRSS Linkedin page Visit NHBRSS youtube page

 

Nunavik Regional Board of Health and Social Services © 2023 All rights reserved.